Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 21626796)

1.

[The statistical analysis of prevalence of anemia in patients with chronic heart failure].

Uskach TM, Kochetov AG, Tereshchenko SN.

Kardiologiia. 2011;51(1):11-7. Russian.

PMID:
21626796
2.

Anemia in chronic heart failure patients: comparison between invasive and non-invasive prognostic markers.

Ceresa M, Capomolla S, Pinna G, Aiolfi E, La Rovere MT, Febo O, Paganini V, Rossi A, Guazzotti G, Caporotondi A, Maestri R, Cobelli F.

Monaldi Arch Chest Dis. 2005 Jun;64(2):124-33.

PMID:
16499298
3.

[Analysis of causes of development of anemia in patients with chronic heart failure].

Tereshchenko SN, Uskach TM, Kochetov AG.

Kardiologiia. 2011;51(5):20-6. Russian.

PMID:
21649592
4.

Prevalance of anemia and its association with cardio-renal syndrome.

Silva RP, Barbosa PH, Kimura OS, Sobrinho CR, Sousa Neto JD, Silva FA, Silva Júnior GB, Mota RM, Daher EF.

Int J Cardiol. 2007 Aug 21;120(2):232-6. Epub 2006 Dec 15.

PMID:
17174420
5.

[Clinical and epidemiological analysis of prevalence and the reasons of the development of anemia in patients with chronic heart failure].

Tsaralunga VN, Vinogradova EL, Zarazhevskaia TS.

Lik Sprava. 2008 Oct-Dec;(7-8):22-31. Russian.

PMID:
19663012
6.

Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.

Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA.

J Am Coll Cardiol. 2011 Sep 13;58(12):1241-51. doi: 10.1016/j.jacc.2011.04.040.

7.

Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure.

Wexler D, Silverberg D, Sheps D, Blum M, Keren G, Iaina A, Schwartz D.

Int J Cardiol. 2004 Jul;96(1):79-87.

PMID:
15203265
8.

The prevalence of anemia in chronic heart failure.

Tanner H, Moschovitis G, Kuster GM, Hullin R, Pfiiffner D, Hess OM, Mohacsi P.

Int J Cardiol. 2002 Nov;86(1):115-21.

PMID:
12400591
9.

The role of exercise ventilation in clinical evaluation and risk stratification in patients with chronic heart failure.

Jankowska EA, Pietruk-Kowalczyk J, Zymliński R, Witkowski T, Ponikowska B, Sebzda T, Rzeczuch K, Borodulin-Nadzieja L, Hańczycowa H, Banasiak W, Ponikowski P.

Kardiol Pol. 2003 Aug;59(8):115-27; commentary 126-7.

PMID:
14560326
10.

[Anemia as a prognostic factor in a population hospitalized due to decompensated heart failure].

Sales AL, Villacorta H, Reis L, Mesquita ET.

Arq Bras Cardiol. 2005 Mar;84(3):237-40. Epub 2005 Apr 15. Portuguese.

11.

Anaemia is an independent predictor of poor outcome in patients with chronic heart failure.

Szachniewicz J, Petruk-Kowalczyk J, Majda J, Kaczmarek A, Reczuch K, Kalra PR, Piepoli MF, Anker SD, Banasiak W, Ponikowski P.

Int J Cardiol. 2003 Aug;90(2-3):303-8.

PMID:
12957766
12.

Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.

Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A, Campagna SM, Nuti R.

Am Heart J. 2006 Dec;152(6):1096.e9-15.

PMID:
17161060
13.

The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinic.

Ezekowitz JA, McAlister FA, Armstrong PW.

Can J Cardiol. 2005 Feb;21(2):165-71.

PMID:
15729416
14.

Prevalence of anemia and renal insufficiency in non-hospitalized patients with heart failure.

Reis FJ, Fernandes AM, Bitencourt AG, Neves FB, Kuwano AY, França VH, Macedo CR, Cruz CG, Sahade V, Aras Júnior R.

Arq Bras Cardiol. 2009 Sep;93(3):268-74. English, Portuguese, Spanish.

15.
16.

Anemia as a risk factor for ischemic heart disease.

Zeidman A, Fradin Z, Blecher A, Oster HS, Avrahami Y, Mittelman M.

Isr Med Assoc J. 2004 Jan;6(1):16-8.

17.

Anemia in chronic heart failure--clinical and prognostic significance.

Karhausen T, Anker SD, Doehner W.

Curr Med Chem Cardiovasc Hematol Agents. 2005 Oct;3(4):297-303. Review.

PMID:
16250861
18.

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, Brosh D, Laniado S, Schwartz D, Yachnin T, Shapira I, Gavish D, Baruch R, Koifman B, Kaplan C, Steinbruch S, Iaina A.

J Am Coll Cardiol. 2000 Jun;35(7):1737-44.

19.

Anemia and its relationship to clinical outcome in heart failure.

Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, Burton PB.

Circulation. 2004 Jul 13;110(2):149-54. Epub 2004 Jun 21.

20.

Acute pulmonary embolism is an independent predictor of adverse events in severe decompensated heart failure patients.

Darze ES, Latado AL, Guimarães AG, Guedes RA, Santos AB, de Moura SS, Passos LC.

Chest. 2007 Jun;131(6):1838-43. Epub 2007 Mar 30.

PMID:
17400665
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk